A detailed history of Hsbc Holdings PLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 4,873,162 shares of ABBV stock, worth $946 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
4,873,162
Previous 4,669,137 4.37%
Holding current value
$946 Million
Previous $850 Million 1.69%
% of portfolio
0.52%
Previous 0.59%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$154.79 - $180.76 $31.6 Million - $36.9 Million
204,025 Added 4.37%
4,873,162 $836 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $84.7 Million - $96.5 Million
530,023 Added 12.81%
4,669,137 $850 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $42.8 Million - $48.2 Million
311,349 Added 8.13%
4,139,114 $641 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $15.6 Million - $18.1 Million
116,861 Added 3.15%
3,827,765 $571 Million
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $110 Million - $137 Million
830,964 Added 28.85%
3,710,904 $500 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $23.2 Million - $26.7 Million
-160,572 Reduced 5.28%
2,879,940 $459 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $137 Million - $164 Million
987,769 Added 48.12%
3,040,512 $492 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $25.2 Million - $28.9 Million
187,441 Added 10.05%
2,052,743 $276 Million
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $41 Million - $52.1 Million
297,626 Added 18.99%
1,865,302 $287 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $33.4 Million - $41.4 Million
-252,799 Reduced 13.89%
1,567,676 $255 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $24.3 Million - $30.7 Million
-225,975 Reduced 11.04%
1,820,475 $246 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $50.2 Million - $57 Million
-471,866 Reduced 18.74%
2,046,450 $222 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $90 Million - $100 Million
-855,683 Reduced 25.36%
2,518,316 $284 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $75.6 Million - $83.2 Million
738,835 Added 28.04%
3,373,999 $365 Million
Q4 2020

Feb 25, 2021

SELL
$80.49 - $108.67 $4.43 Million - $5.98 Million
-55,000 Reduced 2.04%
2,635,164 $282 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $30.8 Million - $41.5 Million
382,293 Added 16.56%
2,690,164 $288 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $52.4 Million - $61.5 Million
609,962 Added 35.92%
2,307,871 $202 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $13.4 Million - $18 Million
182,916 Added 12.07%
1,697,909 $167 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $1.78 Million - $2.7 Million
-27,575 Reduced 1.79%
1,514,993 $115 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $117 Million - $146 Million
-1,619,334 Reduced 51.21%
1,542,568 $137 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $80.5 Million - $96.8 Million
1,278,348 Added 67.87%
3,161,902 $239 Million
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $33.3 Million - $42.6 Million
506,758 Added 36.81%
1,883,554 $137 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $15.6 Million - $18.3 Million
-201,861 Reduced 12.79%
1,376,796 $111 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $2.78 Million - $3.42 Million
35,650 Added 2.31%
1,578,657 $146 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $42 Million - $46.6 Million
-471,864 Reduced 23.42%
1,543,007 $146 Million
Q2 2018

Aug 10, 2018

SELL
$89.78 - $106.23 $144 Million - $170 Million
-1,603,100 Reduced 44.31%
2,014,871 $187 Million
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $94.8 Million - $127 Million
-1,030,611 Reduced 22.17%
3,617,971 $342 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $171 Million - $188 Million
1,911,596 Added 69.84%
4,648,582 $450 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $43.3 Million - $55.3 Million
620,146 Added 29.3%
2,736,986 $243 Million
Q2 2017

Aug 14, 2017

BUY
N/A
2,116,840
2,116,840 $153 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $343B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.